Home › Drug Product Listings

Drug Product Listings

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database
A (1) | B (1) | C (3) | D (3) | E (5) | F (1) | G (2) | I (3) | L (2) | N (1) | O (2) | P (1) | S (3) | T (7) | V (1) | W (1)
Generic Namesort icon Common Trade Name(s) Classification Date Marketed in Canada (yyyy/mm/dd)
Apomorphine Kynmobi Nonergot-derivative dopamine receptor agonist 2020/06/12
Baloxavir marboxil Xofluza Antiviral agent 2020/02/19
Cabotegravir Vocabria Antiretroviral agent 2020/03/19
Cabotegravir + rilpivirine Cabenuva Antiretroviral agent 2020/03/19
Caplacizumab Cablivi Antithrombotic agent 2020/09/04
Daratumumab Darzalex SC Antineoplastic agent, monoclonal antibody 2020/08/12
Darolutamide Nubeqa Anti-androgen 2020/03/24
Drospirenone + estetrol Nextstellis Oral contraceptive 2021/06/15
Elexacaftor + tezacaftor + ivacaftor Trikafta Cystic fibrosis transmembrane conductance regulator correctors 2021/06/22
Entrectinib Rozlytrek Antineoplastic agent
Eptinezumab Vyepti Prevention of migraine; calcitonin gene-related peptide binding antibody 2021/01/11
Eszopiclone Lunesta Hypnotic 2020/10/20
Etonogestrel Nexplanon Hormonal contraceptive 2020/08/17
Fremanezumab Ajovy Anti-calcitonin gene-related peptide 2020/08/04
Gilteritinib Xospata Antineoplastic agent 2020/02/03
Glasdegib Daurismo Antineoplastic agent 2020/08/10
Indacaterol + glycopyrronium bromide + mometasone Enerzair Breezhaler Asthma medication 2020/11/05
Infliximab Avsola Biological response modifier 2020/06/01
Isatuximab Sarclisa Antineoplastic agent, monoclonal antibody 2020/07/03
Larotrectinib Vitrakvi Antineoplastic agent 2019/07/10
Lemborexant Dayvigo Hypnotic 2020/11/06
Niraparib Zejula Antineoplastic agent 2020/01/09
Ofatumumab Kesimpta Immunomudulator 2021/04/08
Onasemnogene Zolgensma Cellular and gene therapy 2021/02/04
Ponesimod Ponvory Sphingosine 1-phosphate receptor modulator 2021/04/28
Satralizumab Enspryng Immunosuppresant 2020/08/26
Sonidegib Odomzo Antineoplastic agent 2020/06/11
Sumatriptan + naproxen Suvexx Serotonin receptor agonist + NSAID 2020/07/24
Tafamidis Vyndaqel Selective stabilizer of transthyretin - cardiac drug 2020/04/07
Tenapanor Ibsrela Sodium/hydrogen exchanger inhibitor 2020/11/23
Tepotinib Tepmetko Protein kinase inibitor (antineoplastic agent)
Teriparatide Osnuvo Bone formation agent 2020/10/27
Tibolone Tibella Hormone replacement therapy 2020/07/29
Trastuzumab deruxtecan Enhertu Antineoplastic agent 2021/04/15
Tucatinib Tukysa Antineoplastic agent 2020/10/08
Voretigene Luxturna Cellular and gene therapy 2020/10/13
Syndicate content